RT Journal Article
SR Electronic
T1 West Nile virus in Portugal
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.02.21251021
DO 10.1101/2021.02.02.21251021
A1 José Lourenço
A1 Sílvia C Barros
A1 Líbia Zé-Zé
A1 Daniel SC Damineli
A1 Marta Giovanetti
A1 Hugo C Osório
A1 Fátima Amaro
A1 Ana M Henriques
A1 Fernanda Ramos
A1 Tiago Luís
A1 Margarida D Duarte
A1 Teresa Fagulha
A1 Maria J Alves
A1 Uri Obolski
YR 2021
UL http://medrxiv.org/content/early/2021/05/17/2021.02.02.21251021.abstract
AB West Nile virus (WNV) causes outbreaks with sustained spillover to humans in many European countries. Despite Portugal’s Mediterranean climate being adequate for WNV transmission, only four human infections have been detected there so far. Here, we offer an historical account of past WNV circulation and develop new, climate-driven insights on the geo-temporal suitability for WNV transmission in Portugal. WNV and vector related literature and database reviews were performed in the context of Portugal covering the time period 1966-2020, and local climate data were used to estimate WNV transmission suitability for the period 1981-2019. Reviewed data demonstrate that WNV-compatible vectors are abundant across the entire country, while molecular and serological evidence for WNV circulation has mostly been associated with the southern districts. Our estimated WNV transmission suitability was found to support geographical differences in transmission potential that favour the southern districts, with an increasing trend over the past forty years due to climate change. Empirical and theoretical evidence supports WNV circulation in Portugal, but it remains unclear whether the virus is endemic or sporadically transmitted. Given the recent public health emergencies related to WNV in other European countries and the findings herein described in relation to Portugal, our study supports a timely change towards a local WNV active surveillance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRelevant funding is included in the Acknowledgements section of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical issues with this manuscript.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is deposited in online repositories and links are included in this manuscript.